Flputnam Investment Management Co. Purchases 549 Shares of Xylem Inc. (NYSE:XYL)

Flputnam Investment Management Co. boosted its position in Xylem Inc. (NYSE:XYLFree Report) by 9.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,432 shares of the industrial products company’s stock after acquiring an additional 549 shares during the period. Flputnam Investment Management Co.’s holdings in Xylem were worth $736,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Bruce G. Allen Investments LLC bought a new position in Xylem in the fourth quarter valued at about $27,000. Coppell Advisory Solutions LLC bought a new position in Xylem during the second quarter worth about $45,000. KB Financial Partners LLC bought a new position in Xylem during the first quarter worth about $42,000. NBC Securities Inc. bought a new position in Xylem during the third quarter worth about $38,000. Finally, Orion Capital Management LLC bought a new position in Xylem during the third quarter worth about $48,000. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

XYL opened at $126.22 on Thursday. The business has a fifty day simple moving average of $126.85 and a 200 day simple moving average of $112.01. The company has a market capitalization of $30.60 billion, a PE ratio of 46.40, a price-to-earnings-growth ratio of 2.55 and a beta of 1.10. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $130.86. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30.

Xylem (NYSE:XYLGet Free Report) last released its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.03. The firm had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.05 billion. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The company’s revenue was up 40.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.92 EPS. Research analysts expect that Xylem Inc. will post 4.13 EPS for the current year.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were issued a dividend of $0.36 per share. The ex-dividend date was Tuesday, February 20th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.14%. This is a boost from Xylem’s previous quarterly dividend of $0.33. Xylem’s payout ratio is 52.94%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on XYL. Royal Bank of Canada raised their target price on Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Wednesday, February 7th. Raymond James raised Xylem from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 4th. Citigroup raised their price target on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research report on Monday, April 8th. Robert W. Baird raised their price target on Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a research report on Thursday, March 21st. Finally, BNP Paribas assumed coverage on Xylem in a research report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $135.44.

Read Our Latest Stock Report on Xylem

Insider Transactions at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is owned by insiders.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Articles

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.